牛叉诊股

[{"date":"2026.06.02","stock":"-1.75","trade":"-1.13","ind":"0.43"},{"date":"2026.06.01","stock":"-1.55","trade":"1.32","ind":"-0.27"},{"date":"2026.05.29","stock":"4.79","trade":"1.30","ind":"-0.73"},{"date":"2026.05.28","stock":"-2.73","trade":"-0.70","ind":"0.12"},{"date":"2026.05.27","stock":"0.35","trade":"-0.49","ind":"-1.25"},{"date":"2026.05.26","stock":"-0.35","trade":"-1.00","ind":"-0.17"},{"date":"2026.05.25","stock":"-1.77","trade":"-0.47","ind":"0.96"},{"date":"2026.05.22","stock":"-1.88","trade":"0.56","ind":"0.87"},{"date":"2026.05.21","stock":"-1.19","trade":"-1.85","ind":"-2.04"},{"date":"2026.05.20","stock":"-3.18","trade":"-0.72","ind":"-0.18"},{"date":"2026.05.19","stock":"1.95","trade":"0.64","ind":"0.92"},{"date":"2026.05.18","stock":"-0.51","trade":"-0.90","ind":"-0.09"},{"date":"2026.05.15","stock":"-2.00","trade":"-0.91","ind":"-1.02"},{"date":"2026.05.14","stock":"-0.11","trade":"-1.27","ind":"-1.52"},{"date":"2026.05.13","stock":"0.95","trade":"-0.26","ind":"0.67"},{"date":"2026.05.12","stock":"0.91","trade":"-1.60","ind":"-0.25"},{"date":"2026.05.11","stock":"1.42","trade":"0.72","ind":"1.08"},{"date":"2026.05.08","stock":"0.50","trade":"0.79","ind":"-0.00"},{"date":"2026.05.07","stock":"0.43","trade":"-0.27","ind":"0.48"},{"date":"2026.05.06","stock":"3.08","trade":"-0.14","ind":"1.17"},{"date":"2026.04.30","stock":"1.60","trade":"0.43","ind":"0.11"}]

达仁堂,上证指数,中药指数

压力支撑

该股压力位为39.61元，支撑位为39.06元。

[{"text":"\u538b\u529b\u4f4d","value":"39.61","date":1780329600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"39.06","date":1780329600,"color":"0x0b52a1"}]

多空趋势

空头行情中，并且有加速下跌的趋势。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：2.6资金面打败了13%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

中药行业，近5日资金总体无进出。

更新时间：06月02日 20:31

机构今日流向(万元)	-1134.09	机构5日流向(万元)	-453.44
机构10日流向(万元)	-4557.80	机构20日流向(万元)	-16941.72

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量减少381.45万股，其中基金净减仓42家，主力净增仓38家，暂未发现中长期投资价值。

截止2025-12-31，共189家主力机构（基金189家），持仓量总计1297.96万股，占流通A股2.29%
其中，基金持仓与2025-06-30相比：
增仓：24家，增持 123.01万股
减仓：66家，减持 149.29万股
新出现在主力名单中：97家，持有249.7万股
从主力名单中消失：59家，原持有604.87万股

消息面诊股

诊断结果：5.6消息面打败了45%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	资产重组	公司股权转让	2026-05-20
一般消息	重大事项	关联交易	2026-05-16
一般消息	股东大会	年度股东大会	2026-04-17
一般消息	募资投向		2026-04-02
利好	分红转增	10派23.4元(含税)	2026-03-31
一般消息	重大事项	关联交易	2026-03-31
利好	重大事项	参股拟上市公司或非上市公司金融机构	2025-12-31
一般消息	高管变动	取消监事会	2025-12-15
利好	分红转增	10派24.5元(含税)	2025-10-31
一般消息	分红转增	不分配不转增	2025-08-15
利好	重大事项	参股拟上市公司或非上市公司金融机构	2025-06-30
一般消息	重大事项	关联交易	2025-06-21

一年消息统计

	所有消息	重大消息	非重大消息
利好	4条	0条	4条
利空	0条	0条	0条

行业面诊股

诊断结果：6.1行业面打败了93%的股票中药行业最新资金流向

近10日来该行业走势不明显，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，接近大盘。

[{"date":"2026.06.02","price":"0.43","value":"-1.13"},{"date":"2026.06.01","price":"-0.27","value":"1.32"},{"date":"2026.05.29","price":"-0.73","value":"1.30"},{"date":"2026.05.28","price":"0.12","value":"-0.70"},{"date":"2026.05.27","price":"-1.25","value":"-0.49"},{"date":"2026.05.26","price":"-0.17","value":"-1.00"},{"date":"2026.05.25","price":"0.96","value":"-0.47"},{"date":"2026.05.22","price":"0.87","value":"0.56"},{"date":"2026.05.21","price":"-2.04","value":"-1.85"},{"date":"2026.05.20","price":"-0.18","value":"-0.72"},{"date":"2026.05.19","price":"0.92","value":"0.64"},{"date":"2026.05.18","price":"-0.09","value":"-0.90"},{"date":"2026.05.15","price":"-1.02","value":"-0.91"},{"date":"2026.05.14","price":"-1.52","value":"-1.27"},{"date":"2026.05.13","price":"0.67","value":"-0.26"},{"date":"2026.05.12","price":"-0.25","value":"-1.60"},{"date":"2026.05.11","price":"1.08","value":"0.72"},{"date":"2026.05.08","price":"-0.00","value":"0.79"},{"date":"2026.05.07","price":"0.48","value":"-0.27"},{"date":"2026.05.06","price":"1.17","value":"-0.14"},{"date":"2026.04.30","price":"0.11","value":"0.43"}]

上证指数,中药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	三力制药	46.04%	19.06%	6.7分
2	粤万年青	39.35%	-0.11%	5.5分
3	众生药业	26.06%	-2.84%	5.6分
4	太龙药业	20.15%	5.15%	6.4分
5	华润江中	8.78%	11.34%	6.2分
6	维康药业	4.65%	-8.00%	5.0分
7	康惠股份	3.97%	1.48%	5.6分
8	济川药业	1.59%	-1.40%	6.5分
9	*ST香雪	0.10%	-1.38%	4.2分
10	ST葫芦娃	-1.18%	-4.14%	5.0分
11	羚锐制药	-1.39%	2.23%	5.5分
12	汉森制药	-2.00%	3.47%	4.7分
13	珍宝岛	-2.40%	-12.31%	4.9分
14	华润三九	-2.92%	4.06%	6.2分
15	达仁堂	-2.98%	-1.06%	4.5分
16	白云山	-3.84%	1.07%	5.4分
17	盘龙药业	-3.94%	1.72%	3.6分
18	昆药集团	-4.11%	8.07%	5.6分
19	天士力	-4.59%	2.14%	5.4分
20	红日药业	-4.97%	0.93%	4.7分
21	桂林三金	-5.17%	1.12%	4.8分
22	仁和药业	-5.45%	-0.55%	4.6分
23	康恩贝	-5.58%	0.24%	6.1分
24	康缘药业	-5.93%	2.76%	5.5分
25	ST百灵	-5.96%	1.07%	4.4分
26	步长制药	-5.96%	0.33%	5.5分
27	东阿阿胶	-5.97%	4.09%	5.7分
28	太极集团	-6.23%	1.89%	5.4分
29	佐力药业	-6.33%	2.50%	5.0分
30	马应龙	-6.57%	2.01%	5.2分
31	-	-6.60%	0.84%	分
32	葵花药业	-6.63%	0.15%	4.7分
33	云南白药	-6.77%	1.25%	4.9分
34	精华制药	-6.86%	1.17%	4.4分
35	奇正藏药	-7.04%	-1.72%	4.4分
36	上海凯宝	-7.04%	-0.56%	3.7分
37	千金药业	-7.36%	-0.97%	5.5分
38	以岭药业	-7.45%	-2.35%	5.2分
39	恩威医药	-7.53%	-16.07%	5.0分
40	同仁堂	-7.60%	1.70%	4.8分
41	佛慈制药	-7.63%	2.79%	5.2分
42	吉林敖东	-8.16%	-1.42%	4.8分
43	方盛制药	-8.30%	-0.60%	5.2分
44	信邦制药	-8.46%	-0.33%	4.7分
45	中恒集团	-8.94%	0.90%	4.8分
46	健民集团	-9.31%	-8.53%	5.0分
47	古汉医药	-9.41%	-1.27%	4.7分
48	亚宝药业	-9.89%	1.27%	4.9分
49	康美药业	-9.94%	-0.65%	4.5分
50	寿仙谷	-10.76%	-1.27%	4.9分
51	华森制药	-10.97%	0.65%	4.8分
52	-	-11.36%	1.26%	分
53	广誉远	-11.46%	-0.80%	4.7分
54	特一药业	-11.78%	0.11%	4.0分
55	振东制药	-11.89%	-1.56%	4.2分
56	益佰制药	-12.10%	-0.56%	4.3分
57	天目药业	-12.51%	-4.02%	4.2分
58	沃华医药	-12.72%	-2.60%	5.0分
59	九芝堂	-12.73%	0.62%	5.5分
60	片仔癀	-13.27%	1.22%	5.1分
61	新光药业	-13.80%	-3.09%	3.6分
62	益盛药业	-14.79%	-3.17%	4.5分
63	新天药业	-15.09%	-4.26%	3.7分
64	陇神戎发	-15.45%	-2.92%	4.1分
65	华神科技	-15.54%	-6.08%	4.3分
66	ST金花	-24.15%	7.84%	5.0分
67	ST嘉应	-29.28%	13.77%	4.7分
68	ST万邦	-45.74%	5.53%	5.3分

<上一页 1 2 3 4 5...12 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：7.6基本面打败了97%的股票连续3年业绩增长30%的公司

该公司运营状况良好，多数机构认为该股长期投资价值较高。

个股深一度

潜在高分红能力：强（100分）

基本面得分最高的股票

[ 截止日期：2026-03-31 ]公司经营

盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 4/107 ， 9/107。

[{"date":"2026-03-31","value":"5.80","vol":"2.21"},{"date":"2025-12-31","value":"28.52","vol":"-2.33"},{"date":"2025-09-30","value":"25.54","vol":"4.80"},{"date":"2025-06-30","value":"23.18","vol":"4.03"},{"date":"2025-03-31","value":"4.66","vol":"2.24"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净资产收益率(%)	5.80	28.52	25.54	23.18	4.66
行业(%)	2.21	-2.33	4.80	4.03	2.24

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"77.71","vol":"55.05"},{"date":"2025-12-31","value":"74.02","vol":"52.85"},{"date":"2025-09-30","value":"74.98","vol":"53.29"},{"date":"2025-06-30","value":"74.67","vol":"53.82"},{"date":"2025-03-31","value":"73.86","vol":"54.48"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
销售毛利率(%)	77.71	74.02	74.98	74.67	73.86
行业(%)	55.05	52.85	53.29	53.82	54.48

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 21/107 ， 25/107。

[{"date":"2026-03-31","value":"4.12","vol":"-5.58"},{"date":"2025-12-31","value":"-32.70","vol":"-6.76"},{"date":"2025-09-30","value":"-34.59","vol":"-7.84"},{"date":"2025-06-30","value":"-33.15","vol":"-7.78"},{"date":"2025-03-31","value":"-30.22","vol":"-7.40"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
营业收入同比增长率(%)	4.12	-32.70	-34.59	-33.15	-30.22
行业(%)	-5.58	-6.76	-7.84	-7.78	-7.40

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"13.24","vol":"1.06"},{"date":"2025-12-31","value":"-4.41","vol":"-80.25"},{"date":"2025-09-30","value":"167.73","vol":"-2.78"},{"date":"2025-06-30","value":"193.08","vol":"2.25"},{"date":"2025-03-31","value":"-3.38","vol":"-37.69"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净利润同比增长率(%)	13.24	-4.41	167.73	193.08	-3.38
行业(%)	1.06	-80.25	-2.78	2.25	-37.69

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 26/107 ， 52/107。

[{"date":"2026-03-31","value":"0.14","vol":"0.12"},{"date":"2025-12-31","value":"0.44","vol":"0.47"},{"date":"2025-09-30","value":"0.33","vol":"0.35"},{"date":"2025-06-30","value":"0.22","vol":"0.24"},{"date":"2025-03-31","value":"0.13","vol":"0.13"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
总资产周转率(次)	0.14	0.44	0.33	0.22	0.13
行业(次)	0.12	0.47	0.35	0.24	0.13

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.31","vol":"0.59"},{"date":"2025-12-31","value":"1.06","vol":"2.34"},{"date":"2025-09-30","value":"0.74","vol":"1.72"},{"date":"2025-06-30","value":"0.54","vol":"1.17"},{"date":"2025-03-31","value":"0.31","vol":"0.59"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
存货增长率(次)	0.31	1.06	0.74	0.54	0.31
行业(次)	0.59	2.34	1.72	1.17	0.59

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-03-31","value":"27.86","vol":"5.83"},{"date":"2025-12-31","value":"-10.36","vol":"30.77"},{"date":"2025-09-30","value":"10.06","vol":"10.53"},{"date":"2025-06-30","value":"11.06","vol":"22.82"},{"date":"2025-03-31","value":"24.43","vol":"2.06"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
现金流量净额/营业收入	27.86	-10.36	10.06	11.06	24.43
行业	5.83	30.77	10.53	22.82	2.06

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.95","vol":"1.00"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.71","vol":"1.03"},{"date":"2025-03-31","value":"","vol":"0.00"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资本支出／折旧和摊销	-	0.95	-	0.71	-
行业	0.00	1.00	0.00	1.03	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 12/107 ， 4/107。

[{"date":"2026-03-31","value":"2.16","vol":"2.97"},{"date":"2025-12-31","value":"1.59","vol":"2.94"},{"date":"2025-09-30","value":"2.81","vol":"3.09"},{"date":"2025-06-30","value":"2.06","vol":"2.94"},{"date":"2025-03-31","value":"2.00","vol":"3.03"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
流动比率	2.16	1.59	2.81	2.06	2.00
行业	2.97	2.94	3.09	2.94	3.03

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.96","vol":"2.23"},{"date":"2025-12-31","value":"0.58","vol":"2.15"},{"date":"2025-09-30","value":"1.08","vol":"2.24"},{"date":"2025-06-30","value":"1.37","vol":"2.15"},{"date":"2025-03-31","value":"1.11","vol":"2.24"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
速动比率	0.96	0.58	1.08	1.37	1.11
行业	2.23	2.15	2.24	2.15	2.24

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 31/107 ， 33/107。

[{"date":"2026-03-31","value":"27.92","vol":"31.94"},{"date":"2025-12-31","value":"39.26","vol":"32.43"},{"date":"2025-09-30","value":"22.11","vol":"31.59"},{"date":"2025-06-30","value":"31.53","vol":"32.45"},{"date":"2025-03-31","value":"26.38","vol":"31.91"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资产负债率(%)	27.92	39.26	22.11	31.53	26.38
行业(%)	31.94	32.43	31.59	32.45	31.91

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.39","vol":"0.66"},{"date":"2025-12-31","value":"0.65","vol":"0.67"},{"date":"2025-09-30","value":"0.28","vol":"0.76"},{"date":"2025-06-30","value":"0.46","vol":"0.75"},{"date":"2025-03-31","value":"0.36","vol":"0.74"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
产权比率 (%)	0.39	0.65	0.28	0.46	0.36
行业(%)	0.66	0.67	0.76	0.75	0.74

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
华创证券	2026-05-15	增持
国海证券	2026-05-06	买入
东北证券	2026-04-24	增持
长城证券	2026-04-02	买入

机构预测

机构预测该股2026年每股收益与前一年相同，长期投资价值一般。

[{"date":"2022","yellowRectValue":"8.62","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"9.87","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"22.29","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"21.31","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"10.79","blueLineValue":"1.40","type":"YC"}]

[达仁堂]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]